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RESEARCH ARTICLE
Pex35 is a regulator of peroxisome abundance
Ido Yofe1, Kareem Soliman2, Silvia G. Chuartzman1, Bruce Morgan3,4, Uri Weill1, Eden Yifrach1, Tobias P. Dick4,
Sara J. Cooper5, Christer S. Ejsing6, Maya Schuldiner1,*, Einat Zalckvar1,* and Sven Thoms2,*
ABSTRACT
Peroxisomes are cellular organelles with vital functions in lipid, amino
acid and redox metabolism. The cellular formation and dynamics of
peroxisomes are governed by PEX genes; however, the regulation of
peroxisome abundance is still poorly understood. Here, we use a
high-content microscopy screen in Saccharomyces cerevisiae to
identify new regulators of peroxisome size and abundance. Our
screen led to the identification of a previously uncharacterized gene,
which we term PEX35, which affects peroxisome abundance. PEX35
encodes a peroxisomal membrane protein, a remote homolog to
several curvature-generating human proteins. We systematically
characterized the genetic and physical interactome as well as the
metabolome of mutants in PEX35, and we found that Pex35
functionally interacts with the vesicle-budding-inducer Arf1. Our
results highlight the functional interaction between peroxisomes
and the secretory pathway.
KEY WORDS: Peroxisomes, Pex35, Ygr168c, Arf1, High-content
screen, Yeast
INTRODUCTION
Of the cellular organelles, peroxisomes are among the most poorly
understood. Peroxisomes are equipped with only a modest number
of proteins (∼100) and have a diameter in the range of the resolution
of light microscopes (∼200 nm) but they are extremely dynamic in
size, number and protein content (Smith and Aitchison, 2013). In
addition, peroxisomes are intriguing and central organelles due to
their involvement in various cellular metabolic pathways, such as
those of lipids, reactive oxygen species (ROS), carbohydrates,
polyamines and amino acids (Wanders and Waterham, 2006), as
well as their contribution to an increasing number of non-metabolic
functions, such as innate immunity (Dixit et al., 2010; Magalhães
et al., 2016; Odendall et al., 2014).
It is not surprising therefore that malfunction of peroxisomes
leads to peroxisome-specific diseases (Braverman et al., 2013;
Weller et al., 2003) and contributes to the pathology of Alzheimer’s
and Parkinson’s diseases, aging, cancer, type 2 diabetes and heart
failure (Beach et al., 2012; Colasante et al., 2015; Fransen et al.,
2013; Islinger et al., 2012; Trompier et al., 2014). A useful
distinction divides peroxisomal diseases into two groups: those in
which single enzymatic functions are defective, and those where
peroxisome biogenesis is defective per se. In peroxisome biogenesis
disorders (PBD), genes involved in peroxisome formation or
maintenance are mutated. Such genes are termed PEX genes, and
the proteins they encode are termed peroxins. In humans, 16 PEX
genes are known (Thoms and Gärtner, 2012; Wanders and
Waterham, 2006). Nearly all of the human PEX genes have
orthologs in yeasts; however, yeasts have additional PEX genes
without obvious homologues in mammals. PEX34 from the yeast
Saccharomyces cerevisiae, a recent addition to the growing list of
PEX genes, encodes a peroxisomal membrane protein that functions
together with the Pex11 family to control peroxisome number
(Tower et al., 2011). The Pex11 family in yeast encompasses the
orthologous proteins Pex11, Pex25 and Pex27, and is involved in
peroxisome division and proliferation (Thoms and Erdmann, 2005).
Therefore, the Pex11 family is also referred to as PEX11-type of
peroxisome proliferators (PPP) (Kettelhut and Thoms, 2014; Thoms
and Gärtner, 2012). Despite the identification of new genes
involved in division and proliferation our understanding of
peroxisome division is still partial, and hence in-depth
characterization of the functions of known effectors as well as
discovery of more players in this process is forthcoming.
Classically, PEX genes have been identified by complementation
screens using mammalian cells or yeast cells (Just and Kunau, 2014).
The earlier yeast screens forPEX genes were based on the finding that
β-oxidation in yeast is exclusively located in the peroxisome so that
only peroxisome-competent cells were supposed to be able to utilize
oleic acid as a sole carbon source (Just and Kunau, 2014). More
recently, it was shown that oleic acid becomes toxic when some
peroxisomal functions are compromised (Lockshon et al., 2007) and
genes with these functions can therefore not be identified in
traditional screen settings. Also, owing to the experimental
limitations inherent in classical forward genetic screens, yeast
screens for peroxisomal functions have identified mainly non-
essential genes with strong phenotypes. Other, non-PEX genes that
are required for peroxisome biogenesis or function have been
identified bymore dedicated approaches. These include the Sec61 ER
translocon complex as an entry point into the endomembrane system
for peroxisomal membrane proteins (Thoms et al., 2011a); or the
ADP-ribosylation factors (ARFs), small GTPases involved in the
control of many vesicular processes, that are also required for
peroxisome formation (Anthonio et al., 2009; Lay et al., 2006).
So how can we identify more proteins required for peroxisomal
function? In recent years this has been achieved by both genome-
wide screens and dedicated proteomic analyses. For example,
proteomics screens of peroxisomes were able to identify new
peroxisomal proteins in fungi (Marelli et al., 2004; Schäfer et al.,
2001; Thoms et al., 2008; Yi et al., 2002), plants (Eubel et al., 2008;
Fukao et al., 2002; Reumann et al., 2007, 2009) and mammalian
tissues, such as rat liver (Islinger et al., 2007, 2010; Kikuchi et al.,Received 10 February 2016; Accepted 24 November 2016
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2004), mouse liver and kidney (Mi et al., 2007; Ofman et al., 2006;
Wiese et al., 2007), and human liver (Gronemeyer et al., 2013). In
addition, several genome-wide genetic screens in yeast have shed
light on new proteins and their potential functions. For example,
fitness and transcriptome responses to oleic and myristic acid have
been used to define the networks underlying the metabolic
responses to these fatty acids and to identify new proteins
involved in peroxisome function (Lockshon et al., 2007; Smith
et al., 2002, 2006). A collection of kinase and phosphatase gene
deletion strains has also been evaluated for the expression of the
peroxisomal matrix protein enzyme 3-ketoacyl-CoA thiolase (Pot1)
(Saleem et al., 2008). Following a similar approach, a genome-wide
screen for alterations in the expression of a GFP-labeled
peroxisomal matrix protein led to the identification of 169 genes
required for all the processes that lead to faithful biogenesis
and propagation of peroxisomes (Saleem et al., 2010). Other
systematic approaches including high-throughput experiments with
quantitative analysis and modeling have been used to complete the
peroxisomal proteome and to improve the understanding of
peroxisome metabolism and biogenesis (Cohen et al., 2014;
Wolinski et al., 2009). More recently, systematic high-content
screens and bioinformatics analyses led to the identification of a
new peroxisomal targeting protein, Pex9, and two new peroxisome
matrix proteins, Pxp1 and Pxp2 (Effelsberg et al., 2016; Nötzel
et al., 2016; Yifrach et al., 2016; Yofe et al., 2016). With each new
study revealing additional new peroxisomal proteins it is clear that
we have not yet saturated our understanding of the peroxisomal
proteome and new peroxisomal proteins await discovery.
In this work, we report the results of a high-content screen in
the yeast Saccharomyces cerevisiae, tailored to uncover mutants
affecting peroxisome abundance. By creating a systematic library
of gene mutants in yeast cells expressing a fluorescent marker
for peroxisomes, followed by automated microscopy and
computational image analysis, we identified a previously
uncharacterized protein affecting peroxisome abundance. We
show that this protein, which we name Pex35, is a peroxisomal
membrane protein that controls peroxisome abundance.
RESULTS
A high-content screen uncovers regulators of peroxisome
size and number
In order to identify genes that regulate peroxisome number or size,
we wanted to quantify these parameters in mutants of every yeast
gene. To this end we created a query strain that enables visualization
of peroxisomes and is compatible with the Synthetic Genetic Array
(SGA) automated mating approach in yeast (Cohen and Schuldiner,
2011; Tong and Boone, 2006). The strain expressed the peroxisomal
membrane protein Pex3 tagged with the red fluorescent protein
mCherry (Pex3–mCherry), and a fluorescent marker for the
endoplasmic reticulum (ER), Spf1–GFP, to enable automated cell
segmentation. The query strain was then crossed into nearly 5000
strains of the deletion library (Giaever et al., 2002) and more than
1000 strains of the DAmP (Decreased Abundance by mRNA
Perturbation) hypomorphic allele library for essential genes
(Breslow et al., 2008). Following sporulation and selection of
haploids, we obtained about 6000 unique haploid strains, each
mutated in one yeast gene and marked with Pex3–mCherry and
Spf1–GFP. This screening library was subjected to automated
image acquisition and analysis during growth in glucose. Using an
automated high-content microscopy setup specifically configured
for this purpose (Breker et al., 2013), we recorded three images
covering hundreds of cells per strain (Fig. 1A). We then developed a
computational pipeline using the green fluorescent ER marker to
find individual cells and counted the mean size of peroxisomes as
well as their number per cell (Fig. S1). When analyzing peroxisome
size (Fig. 1B; for complete data see Table S1) we found that mean
cell peroxisome size varied through a range of approximately six-
fold. Although some peroxisomal proteins and proteins associated
with peroxisome formation were enriched at the edges of the
distribution, there was no strong enrichment or near-complete
coverage of mutants in peroxisomal proteins or peroxisome
biogenesis factors in the strains with decreased or increased
peroxisome size. Rather, genes controlling mitochondrial function
or localization were dramatically enriched. Among the top 130
mutants with enlarged peroxisomes, 80 were mitochondrial proteins
(five-fold enrichment, P-value=2×10−31) (Eden et al., 2009),
confirming a tight connection between peroxisomes and
mitochondria (Cohen et al., 2014; Mohanty and McBride, 2013;
Schrader et al., 2013; Thoms et al., 2009). Indeed it is known that
when mitochondrial metabolism is compromised, cells can
compensate by upregulating peroxisome metabolism and size
(Eisenberg-Bord and Schuldiner, 2016). Interestingly, a mutant
causing some of the smallest peroxisomes was defective in
carbamoyl phosphate synthase (Cpa1), which is important for the
biosynthesis of the amino acid citrulline. These findings indicate
that peroxisome size is not the best parameter to identify new
peroxisomal proteins. However, the information regarding size may
be used in the future to further understand the factors that create the
functional link between mitochondria and peroxisomes.
When focusing on peroxisome number, we noticed that mutants
with increased peroxisome number were not enriched for
peroxisomal proteins and seemed to have defects in central
cellular processes like translation, chromatin control or
cytoskeletal dynamics (Fig. 1C; Table S1). However, the strains
with the strongest reduction in peroxisome number were strikingly
enriched in known peroxisomal membrane proteins (105-fold
enrichment, P-value=10−26) (Eden et al., 2009) (Fig. 1C). Among
those are strains known to affect peroxisome morphology (Δpex19,
Δpex27, Δinp1 and Δvps1). At the other end of the spectrum, loss of
Pex17, a protein that is associated with the docking complex for
peroxisome matrix protein import (Huhse et al., 1998), caused a
drastic increase in peroxisome number. Importantly, several
unknown proteins affected peroxisome number to a similar extent
as mutations in known peroxisomal proteins [Fig. 1C (inset) and
Table 1]. Of those, the most highly ranking uncharacterized open
reading frame was YGR168C.
Deletion or overexpression of YGR168C affects peroxisome
number and function
We decided to focus on YGR168C since a deletion of this previously
uncharacterized gene caused a decrease in peroxisome abundance that
is as dramatic as defects in the known peroxisomal biogenesis and
inheritance proteins Pex12 and Vps1 (Fig. 2A). To ensure that this
phenotype is independent of the peroxisomal marker (Pex3–mCherry)
that we chose for the initial screen, we deleted YGR168C in four
strains with GFP-tagged peroxisomal markers, including both matrix
and membrane proteins. We found that peroxisome recognition of our
image analysis program depended on the intensity of the marker used
and the analysis settings. Therefore, peroxisome abundance values
frommeasurement of fluorescent markers should be stated in arbitrary
units that may only be used to compare between strains with the same
marker. However, regardless of the marker used, loss of YGR168C
caused a significant reduction in peroxisome number per cell when
compared to a control strain (Fig. 2B).
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Next, we manipulated Ygr168c protein expression by putting
it under control of the strong TEF1 promoter (TEF1prom).
Overexpression of YGR168C also led to a decrease in
peroxisomal fluorescent puncta either in glucose (Fig. 2C) or
oleic acid as a sole carbon source (Fig. 2D). The fact that both
deletion and overexpression caused similar phenotypes was
puzzling to us and we decided to follow peroxisomal architecture
in more detail.
Super-resolution microscopy demonstrates that YGR168C
overexpression leads to multi-lobular peroxisome
morphology
To better characterize the effect on peroxisomes produced by
either deletion or overexpression of YGR168C we analyzed
peroxisome size and morphology by stimulated emission
depletion (STED) microscopy. Strains were transformed with a
plasmid expressing a peroxisome-targetedGFP variant (EYFP–SKL)
Fig. 1. A high-content screen uncovers regulators of peroxisome size and number. (A) Schematic representation of the high-content screen workflow. A
query strain containing the peroxisomal marker Pex3–mCherry and the ER marker Spf1–GFP was crossed with strain collections of gene deletions and
hypomorphic alleles. Following selection, the resulting haploid yeast each contained both a single mutation and the markers. The libraries were imaged using a
high-throughput automatedmicroscope. Imageswere analyzed by software-assisted single-cell and object (peroxisome) recognition, allowing the identification of
mutants that show aberrant peroxisome size or number. (B) Distribution of the Z score of the mean peroxisome size for successfully analyzed mutant strains.
Mutants of peroxisomal membrane proteins are marked in red, and other peroxisomal proteins marked in black. (C) Distribution of the Z score of the mean
peroxisome number per cell for successfully analyzed mutant strains. A high enrichment of peroxisomal membrane protein mutants and Δpexmutants is found in
the group of decreased peroxisome number, as illustrated by the inset pie chart, presenting functional classes of the 30 mutants in this group. YGR168C is a
previously uncharacterized gene found within this group. Mutants of peroxisomal membrane proteins are marked in red, and other peroxisomal proteins are
marked in black.
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and were analyzed by fluorescence nanoscopy using nanobodies
directed against GFP.
First, using STED microscopy we determined the size of
peroxisomes with unprecedented accuracy. We used images of
71 peroxisomes to determine that the diameter of wild-type
peroxisomes is 174 nm (±8 nm, s.e.m.), which is below the
resolution of conventional light microscopy (Fig. 3A,D;
Fig. S2A). Second, these images, as opposed to regular
diffraction-limited analysis, revealed a clue as to the basis of the
function of YGR168C. While the number of peroxisomes was
reduced in Δygr168c, their size was not (Fig. 3B,D; Fig. S2A).
However, peroxisomes in the overexpressing strain, which appeared
to be enlarged in confocal microscopy analysis, showed a striking
multi-lobular morphology when analyzed by STED microscopy
(Fig. 3C,D; Fig. S2A). This phenotype may be due to hyper-fission
of the organelles into tiny peroxisomes, which clump together
giving the false impression of a single big peroxisome when
visualizing cells by fluorescence microscopy; alternatively the
multi-lobular phenotype may be due to the initiation of a
proliferation process that is aborted at an early stage. Both
scenarios are compatible with a role of Ygr168c in controlling
peroxisome fission. Loss of YGR168C may therefore cause the
opposite effect – reduction in fission – causing the observed
reduction in peroxisome number. Taken together our results
demonstrate that Ygr168c is a bona fide regulator of peroxisome
number and size in yeast.
YGR168C is a new PEX gene, which we denote PEX35
Since Ygr168c has such a strong effect on peroxisome number
and size, we wanted to better characterize this protein. The
C-terminally tagged strain could not be visualized above
background autofluorescence when expressed under its own
promoter in cells growing in glucose medium, indicating that
expression of the protein in glucose medium is very low. When we
expressed the protein with either a C- or N-terminal fluorescent tag
under control of the medium strength TEF1 promoter, Ygr168c
tagged on either terminus was localized to punctate structures that
completely colocalized with the peroxisomal markers Pex3–
mCherry or Pex3–GFP (Fig. 4A). The Ygr168c protein is
predicted by TMHMM (Krogh et al., 2001) and TOPCONS
(Bernsel et al., 2008) to be a membrane protein with five
transmembrane domains and a large C-terminal domain facing the
cytosol (Fig. 4B). We examined the expression and localization of
GFP–Ygr168c in the absence of Pex19, a farnesylated membrane
protein biogenesis factor (Rucktäschel et al., 2009). In Δpex19
cells, the residual GFP signal is distributed in the cytosol and the
ER (Fig. 4C). These findings further support that Ygr168c is a
peroxisomal protein that is withheld in or mislocalized to the ER in
the absence of Pex19. Similar results were obtained in the absence
of PEX3. GFP–Ygr168c expression was reduced and the residual
GFP signal was distributed in the cytosol and the ER (Fig. S2B), in
agreement with Ygr168c being a peroxisomal protein. To confirm
that Ygr168c is a bona fide peroxisomal protein, we purified
peroxisomes from oleate-induced wild-type cells with a GFP-
marked Ygr168c. Ygr168c was recovered from the peroxisome
fraction of the Nycodenz density gradient (24%–35% interface) and
was absent in the cytosolic and the mitochondrial fractions
(Fig. 4D).
The N-terminal domain of Ygr168c is predicted to contain a
mitochondrial-targeting signal (MTS) (Emanuelsson et al., 2007).
As some peroxisomal membrane proteins can be dually targeted to
mitochondria, we analyzed the intracellular localization of an
N-terminal fragment of Ygr168c comprising the first and second
predicted transmembrane domain (TMD; amino acids 1 to 107) that
contain the predicted MTS as a fusion protein with mCherry.
Mitochondrial targeting of the truncated protein was not observed,
suggesting that the N-terminal domain does not function as an MTS
in this context or under these conditions. Interestingly, this fusion
protein now localized to both the ER and peroxisomes (Fig. 4E), in
agreement with the proposed passage of peroxisomal membrane
proteins through the ER (van der Zand et al., 2010). Our finding also
suggests that peroxisome-specific targeting information is in the
C-terminal domain of Ygr168c.
The hallmark of many strains with a defect in maintaining normal
peroxisome abundance is a growth defect when grown on oleic acid
as the sole carbon source. Indeed, the deletion of YGR168C did not
affect growth on glucose (Fig. S2C), yet showed reduced growth
and reduced formation of halos on oleic acid medium,
demonstrating the lack of oleic acid consumption (Fig. S2D).
Interestingly, the overexpression did not give a similar phenotype
(Fig. S2E). However, overexpression of a GFP-tagged isoform
(TEF1prom:GFP-YGR168C) did cause a phenotype suggesting that
it somehow aggravates the effect of overexpression or creates a
dominant negative (Fig. S2E). Growth curves of these strains on
oleate as a sole carbon source confirm this finding: the growth of
Δygr168 and TEF1prom:GFP-YGR168C is slower than a control
strain although is better than Δpex3 (Fig. 4F). Quantitative
assessment of oleate consumption at the end point of the growth
assay showed that mutant cells indeed utilized less of the available
oleic acid (Fig. 4G).
Finally, we assayed the accumulation of peroxisomes in real time.
The GAL1 promoter was introduced to regulate GFP–Ygr168c in a
strain containing Pex3–RFP as a peroxisomal marker. Time-lapse
microscopy following a transfer of this strain from glucose- to
galactose-containing medium showed that GFP–Ygr168c
accumulated in Pex3-marked peroxisomes. Furthermore, while
cells that did not show GFP–Ygr168c expression had a normal
peroxisome abundance, cells with GFP–Ygr168c expression
displayed an abnormal phenotype of one enlarged peroxisome per
cell over time (Fig. 4H).
Table 1. Top hits of the microscopic screen for proteins involved in
peroxisome formation
Rank Gene Protein Abundance
1 YDL065C Pex19 −7.6
2 YKR001C Vps1 −6.0
3 YOL044W Pex15 −5.5
4 YNL329C Pex6 −5.5
5 YOR193W Pex27 −5.3
6 YKL197C Pex1 −5.2
7 YDR265W Pex10 −4.9
8 YMR204C Inp1 −4.7
9 YGR077C Pex8 −4.7
10 YJL210W Pex2 −4.6
11 YCL056C Pex34 −4.4
12 YPL112C Pex25 −4.4
13 YMR026C Pex12 −4.1
14 YMR205C Pfk2 −4.0
15 YMR163C Inp2 −4.0
16 YLR191W Pex13 −3.5
17 YGR168C −3.2
18 YDR233C Rtn1 −2.9
19 YLR126C −2.8
20 YPR128C Ant1 −2.7
21 YOR084W Lpx1 −2.4
Abundance: peroxisome number per cell (Z score).
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Taken together, these data show that Ygr168c is a new
peroxisomal membrane protein in yeast. Manipulation of the
expression level of Ygr168c led to changes in peroxisome
number and size, as well as to growth defects on oleate. As
Ygr168c bears all signs of a peroxin, we named it Pex35.
Characterizing the molecular function of Pex35
Having identified a new peroxisomal membrane protein, we were
eager to functionally characterize it and understand how it exerts its
effect on peroxisome number and size. Since peroxisomes have an
important role in lipid metabolism, we first performed a detailed
lipidomic analysis but could find no significant changes in whole-
cell lipid composition compared to a control strain (Table S2). This
result suggests that Pex35 does not influence gross membrane lipid
composition. Coupled with the relatively small growth defect of
Δpex35 strains grown on oleic acid our results suggest that Pex35 is
not directly involved in lipid metabolism.
We then performed a synthetic growth screen to try and uncover
proteins or pathways that become important when cells are lacking
Pex35. In this screen, a Δpex35 strain was crossed with the libraries
comprising the∼6000 deletion and hypomorphic strains that we had
previously used for the visual screen. After mating, sporulation and
selection of haploids, growth of the double mutants was compared
to growth of the individual mutant strain (Table 2; Table S3).
Focusing on synthetic lethal interactions where the double mutants
are dead while each single mutant is alive, we saw that redox
homeostasis becomes important in the absence of Pex35. For
example, deletion of the glutathione (GSH) synthetase (GSH2)
required for the synthesis of GSH from γ-glutamyl cysteine and
glycine was synthetic lethal with Δpex35. This suggests that the
mutant strongly depends on a reducing environment for survival. To
test this, we measured the glutathione redox potential in the
peroxisomal matrix using a newly described peroxisomal reporter
(Elbaz-Alon et al., 2014). Notably, overexpression of Pex35 had
Fig. 2. Deletion or overexpression of YGR168C affects peroxisome number and function. (A) Examples of mutants from the high-content screen
showing aberrant peroxisome content. Images of strains from the high-content screen containing Pex3–RFP and Spf1–GFP. Peroxisome size is increased in
Δvps1, and peroxisome number is decreased inΔvps1,Δpex12 and Δygr168c, compared to awild-type (WT) strain. Scale bar: 5 µm.Graph shows quantification of
these parameters (see also Fig. S1). n>72, ***P<0.01 compared with WT (t-test). (B) Reduction in peroxisome number in Δygr168c is independent of the
peroxisomalmarker used. The numberof peroxisomes per cell was analyzed by using several peroxisomalmembrane ormatrix proteins taggedwithGFP, either in
a WT or Δygr168c background. The decrease in peroxisome number in Δygr168c is seen with all peroxisome markers used, n=6. ***P<0.01 (Δygr168c versus
WT; t-test foreachmarker). (C)OverexpressionofYGR168C reduces thenumberof peroxisomepuncta. Imagesof strainswithPex3–GFPand that areWT,Δygr168c
or overexpress YGR168C (OE-YGR168C). Scale bar: 5 µm. (D) Peroxisome number is affected in ygr168cmutants grown in glucose and oleate. Quantification of
mean cell peroxisome number per cell in WT, Δygr168c, or OE-YGR168C cells, visualized after growth in either glucose (gray) or oleate (red) medium. While an
increase in peroxisome number is observed in oleate compared to glucose for each strain, peroxisome number is decreased in the mutants compared to WT in
glucose medium, and in OE-YGR168C in oleate. n>731. ***P<0.01 compared with the same medium for WT (t-test). All quantitative data are mean±s.e.m.
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already caused a substantial pro-oxidative shift under steady state
conditions. Moreover, following treatment with a bolus of hydrogen
peroxide, the probe remained more reduced in the deletion strain
whereas it became more oxidized upon overexpression of Pex35
(Fig. S2F).
Other pathways that were over-represented were those of
polyamine, cysteine, lysine and arginine biosynthesis (Table 2).
To test how amino acid levels are altered in the absence of Pex35,
we extracted metabolites from wild-type, Δpex35, TEFprom:
GFP-PEX35 and Δpex3 strains. We used high-performance liquid
chromatography (HPLC)-based metabolomics to characterize
amino acid levels in each strain and found that amino acid levels
were indeed significantly affected (Fig. S2G). There was a
remarkable 70% reduction in the level of citrulline in Δpex35,
which was matched by a more than two-fold increase of citrulline in
TEFprom:GFP-PEX35. This was in agreement with the strong
lethality of this strain in combination with mutants in the arginine
biosynthetic pathway. These findings reinforce the notion that
peroxisomes in yeast are important in regulating or executing
aspects of amino acid metabolism (Natarajan et al., 2001), and
highlights how defects in mitochondrial function (such as in
arginine biosynthesis) can activate the retrograde response to
enhance peroxisomal functions (Chelstowska and Butow, 1995).
Pex35 is located in the proximity of Pex11 family proteins
and Arfs
So far, our data suggested that Pex35 is a peroxisome membrane
protein affecting peroxisome number and size, as well as
redox and amino acid homeostasis. To try and understand the
mechanism by which Pex35 functions, we performed a systematic
complementation assay using the two parts of a specially adapted
dihydrofolate reductase (DHFR) enzyme (Tarassov et al., 2008). In
this assay, one half of the DHFR enzyme is fused to Pex35 (‘bait’),
which is expressed in∼5700 yeast strains expressing fusions of each
individual proteins with the other half of DHFR (‘prey’). When the
Pex35 bait is in proximity to one of the library prey proteins,
methotrexate-resistant DHFR activity is reconstituted, and cells can
grow in the presence of methotrexate, an inhibitor of the
endogenous essential DHFR activity (Fig. 5A).
When seeking for growth with an N-terminally tagged Pex35, we
could not find any high-confidence complementing proteins,
suggesting that the N-terminus is essential for the interaction of
Pex35 with effector proteins localized at the peroxisome (data not
shown) and reinforcing the previous notion that the overexpression
of an N-terminally tagged GFP–Pex35 is more toxic than regular
Fig. 3. STED microscopy reveals characteristics of wild-type and ygr168c
peroxisomes. (A–C) Examples of STED super-resolution microscopy of wild-
type (WT; A), Δygr168c (B) and strains overexpressing YGR168C (OE-
YGR168C; C) expressing EYFP–SKL as a peroxisomalmarker and labeled with
anti-GFP nanobodies. Scale bar: 200 nm. The size of peroxisomes was
determined as the FWHM of a Gaussian fit. Dashed lines, positions of size and
cluster measurements. Peroxisome diameter in Δygr168c is not altered.
Overexpression of YGR168C causes an increase in the apparent size of
peroxisomes. In conventional light microscopy, these aggregates appear as
enlarged single peroxisomes. Sub-diffraction imaging reveals that enlarged
peroxisomes consist of multi-lobular structures, whereby the individual
substructures appear as peroxisomes of wild-type-like morphology. The
distances between the maxima varies between 137 and 174 nm. (D) The mean
diameter of WT peroxisomes is 174±8 nm (s.e.m.). The size difference between
wild-type and knockout peroxisomes 96±7 nm (s.e.m.) was not significant
(P=0.1). The mean diameter of OE-YGR168C peroxisome clusters is 285 nm
(±16 nm s.e.m.) (***P=6×10−8 compared with WT). n>50 in all cases.
796
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 791-804 doi:10.1242/jcs.187914
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Fig. 4. See next page for legend.
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overexpression. However, when we performed the assay with a
C-terminally tagged strain, either under the native Pex35 promoter
or the strong TEF1 promoter, we identified 11 proteins previously
known to be involved in peroxisomal functions among the top 16
hits (Fig. 5B,C; Table S4). These included Pex19, the peroxisomal
membrane protein chaperone, supporting the notion that Pex35 is a
membrane protein. Other proteins that were in the vicinity of Pex35
were peroxisomal membrane proteins or membrane-associated
proteins (enrichment factor 70, P=1.6×10−17) (Eden et al., 2009).
Especially intriguing was the identification of the Pex11 family
proteins, Pex11 and Pex25, and Arf1, because these proteins have
previously been shown to interact with each other, and all of them
have a role in peroxisome fission, a process that would affect
peroxisome number and size (Fig. 5B,C).
Pex35 modulates the effect of Arf1
To examine whether the physical proximity with Arf1 can explain
the effect of Pex35 on peroxisome abundance, we first tested
whether the abundance of Arf1 or the localization of Arf1–mCherry
were affected by deleting or overexpressing Pex35. We found that
both deletion and overexpression of PEX35 dramatically increased
Arf1 levels (Fig. S3A). Moreover, PEX35 also affected Arf1–
mCherry distribution. In control strains, Arf1 localizes mainly in
punctate structures, in agreement with the Golgi localization of Arf1
(Stearns et al., 1990). However, when PEX35 was deleted or the
tagged form was overexpressed, Arf1 redistributed to various
internal membranes (Fig. 6A). It is well known that, while the
C-terminal tag of Arf1 creates a dysfunctional form, it does report
accurately on its subcellular localization (Huh et al., 2003; Jian
et al., 2010).
Arf1 has previously been implicated in peroxisome formation
(Anthonio et al., 2009; Lay et al., 2005; Passreiter et al., 1998). We
therefore investigated whether Pex35 was mediating its effect on
peroxisome abundance through Arf1 by looking at the effect of
Δpex35 deletion or overexpression on the background of loss of
Arf1 (Δarf1). Deletion of ARF1 in the Δpex35 knockout lead to a
marked increase in peroxisome size and aggravated the effect of
Δpex35 on peroxisome number (Fig. 6B,C). Even more striking, the
deletion of ARF1 in the Pex35-overexpressing strain rescued the
peroxisome-enlarging effect of Pex35 overexpression and
normalized the number of peroxisomes to control levels (Fig. 6B,C).
These findings suggest that Pex35 exerts its function through a
mechanism that requires Arf1.
Next, we wanted to analyze Arf1 at the organellar level. We
purified peroxisomes by cell fractionation from strains that
contained both GFP-tagged Pex3 as a peroxisome marker and
RFP-tagged Arf1, either in a wild-type or in a Δpex35 background
(Fig. S3B). The absence of the peroxisome marker in the cytosol or
the mitochondria fraction showed that other compartments were free
from peroxisomes. Arf1–RFP was clearly enriched in the
peroxisome and mitochondria fractions, in agreement with the
results of the quantitative whole-cell analysis (Fig. S3A). The
distinction of peroxisomal and mitochondrial pools of Arf1,
however, was not possible in this experiment, because the ‘light-
mitochondrial’ faction co-fractionates with peroxisomes in the step
gradient.
Our findings on the effects of Pex35 on Arf1 made us wonder
whether altering PEX35 could exert an effect on the secretory
pathway functions of Arf1 (Fig. 6A). In order to test whether Arf1-
dependent anterograde traffic was affected, we tested secretion of
Fig. 4. YGR168C (PEX35) is a new PEX gene. (A) Ygr168c colocalizes with a
peroxisomal marker. Overexpressed (OE) N-terminally GFP-tagged Ygr168c
colocalizes with Pex3–mCherry, with a notable phenotype of about one large
peroxisome per cell (top). Overexpression of Ygr168c with a C-terminal
mCherry tag displays colocalization with Pex3–GFP (bottom) with wild-type
(WT) peroxisome abundance. Scale bars: 5 µm. (B) Predicted transmembrane
topology of Ygr168c (Pex35). Transmembrane helices were predicted by the
TMHMM algorithm (v2.0). The schematic representation demonstrates the five
transmembrane domains, as well as a long cytoplasmic C-terminus for the
protein. (C) Deletion of PEX19 leads to the cytosolic localization and ER
accumulation of Ygr168c. sfGFP, superfolder GFP. Scale bar: 5 µm.
(D) Identification of GFP–Ygr168c on purified wild-type peroxisomes isolated
from oleate-induced cells. Western blot analysis of the post-nuclear
supernatant (PNS), and cytosol (Cyt), peroxisomal (Px) and mitochondrial
(Mito) fractions from the Nycodenz step gradient. Anti-Por1 antibody is used as
a mitochondrial marker. (E) Overexpression of amino acids 1–107 of Ygr168c
(Ygr168c1-107; including the N-terminal region and the first two predicted
transmembrane domains) tagged with mCherry displays colocalization with
Pex3–GFP, and also shows localization to the ER. Scale bar: 5 µm.
(F)YGR168Cmutants growmore slowly inmedium containing oleic acid as the
sole carbon source. WT, Δygr168c, OE-YGR168C and Δpex3 strains were
grown in oleic acid for 128 h, and the OD600 was measured to assess growth.
YGR168Cmutants display a significant growth defect, at an intermediate level
between WT and the Δpex3. Error bars indicate s.d., n=4. (G) YGR168C
mutants consume less oleic acid. Media from the end-point of the experiment
described in D (128 h) were used to assess the relative oleic acid consumption
of each strain. Error bars indicate s.d., n=4. ** P<0.05 (t-test). (H) Induction of
GFP–Ygr168c leads to accumulation of the protein in peroxisomes, and to
aberrant peroxisome content. A strain expressing both Pex3–RFP and GFP–
Ygr168c under the control of the inducibleGAL1 promoter was transferred from
glucose to galactose medium. Time-lapse imaging was carried out starting
from 90 min (t=0). GFP–Ygr168c becomes highly induced under these
conditions and colocalizes with Pex3–RFP over time. Notably, cells in which
GFP–Ygr168c is not expressed (arrows) display normal peroxisome content,
while cells in which expression is induced display one large peroxisome in
each cell. Scale bar: 5 µm. Dashed lines in images highlight cell outlines.
Table 2. Top hits of the PEX35 synthetic genetic interactions screen
Rank Gene Protein SM DM DM/SM
1 YOR130C Ort1 0.86 0.24 0.27
2 YKL184W Spe1 0.67 0.19 0.29
3 YNL268W Lyp1 0.13 0.04 0.34
4 YCR028C-A Rim1 0.12 0.05 0.39
5 YDR234W Lys4 0.81 0.32 0.40
6 YJL101C Gsh1 0.22 0.11 0.47
7 YBR081C Spt7 0.20 0.10 0.48
8 YJL071W Arg2 0.21 0.11 0.51
9 YNL270C Alp1 1.30 0.69 0.53
10 YER116C Slx8 0.25 0.14 0.54
11 YGL143C Mrf1 0.49 0.28 0.57
12 YBR251W Mrps5 0.13 0.07 0.57
13 YNL005C Mrp7 0.30 0.17 0.58
14 YHR147C Mrpl6 0.19 0.11 0.61
15 YER185W Pug1 1.51 0.94 0.62
16 YGL076C Rpl7a 0.49 0.31 0.63
17 YMR142C Rpl13b 0.49 0.32 0.65
18 YPR099C Ypr099c 0.30 0.20 0.66
19 YDR028C Reg1 0.37 0.24 0.66
20 YCL058C Fyv5 0.67 0.44 0.66
21 YJL088W Arg3 0.37 0.25 0.68
22 YDR448W Ada2 0.36 0.24 0.68
23 YOL108C Ino4 0.47 0.32 0.69
24 YOL095C Hmi1 1.22 0.84 0.69
25 YDL077C Vam6 1.06 0.73 0.69
26 YBR196C-A Ybr196c-a 0.40 0.28 0.69
27 YDR017C Kcs1 0.82 0.57 0.69
28 YBR282W Mrpl27 0.45 0.31 0.69
29 YJR118C Ilm1 0.74 0.51 0.69
30 YNL252C Mrpl17 0.28 0.20 0.69
SM, normalized colony size of single mutant; DM, normalized colony size of
double mutant; DM/SM: colony size ratio of the double to single mutant.
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the intra-ER chaperone Kar2 (a BiP homolog). The slow leak of
Kar2 from the ER, through the Golgi and its secretion into the
medium is a good way to observe dysregulated secretion (Copic
et al., 2009). Indeed, overexpressing GFP–Pex35 (which led to a
drastic increase in Arf1 levels) decreased secretion to 50% or less,
similar to what is seen upon directly overexpressing Arf1 (Fig. 6D).
Interestingly, the deletion of PEX35 (although also leading to Arf1
overexpression) could compensate for the effect of Arf1
overexpression, suggesting that in normal physiology PEX35
restrains Arf1 function (Fig. 6D). Equally striking was the finding
that the deletion of PEX3 alone exerted a secretion defect in the
same range, like strong activation of the unfolded protein response
(UPR; seen by deletion of the ER protein SPF1), or the
overexpression of Pex35 or Arf1 (Fig. 6D). To follow up this
finding, we tested the localization of Arf1–RFP in a Δpex3
background. The deletion of PEX3 led to a surprising loss of
focal Arf1 localization (Fig. 6E). At this point it is not clear whether
this is due to a direct association of Arf1 with Pex3 or Pex35, or if it
is due to the upregulation of Arf1 or the large proportion of Arf1
associated with peroxisomes that is altered upon Pex3 loss, but in all
these cases, these data point to a strong role for peroxisomes in the
function of the secretory pathway.
DISCUSSION
One of the current challenges in molecular cell biology is to
integrate multiple levels of understanding spanning holistic omics
approaches and detailed analysis of single molecular entities. In this
study, we go through such an analysis, starting from a large-scale
genetic screen with the complete deletion and DAmP collection,
and end up with the identification of a new peroxisomal protein and
insights into the mechanism by which it may regulate peroxisome
abundance.
The initial screen relied on three automated stages: generation of a
screening library comprising deletions and functional knockdowns
of nearly all yeast genes, automated image acquisition, and a
computational pipeline for image segregation and quantification.
This approach complements the classical forward genetic screen
based on growth on oleate, with the advantage of increased
sensitivity gained by statistical analysis of quantitative data. Our
screen was stringent as well as exhaustive – most other genes
previously implicated in many aspects of peroxisome formation,
inheritance and maintenance clustered on the top of our scoring list.
We found that, although some strains defective in peroxisome
proliferation have a strongly altered (reduced) peroxisome size,
reduction in peroxisome number is a more exhaustive criterion to
cover genes required for peroxisome formation and maintenance.
Of the genes with the strongest effect on peroxisome number, we
decided to focus on YGR168C, which we termed PEX35. We show
that Pex35 is a peroxisomal membrane protein that had not been
identified previously, probably due to its low expression level in
cells grown on glucose and its moderate, yet quantifiable, effect on
peroxisome number and size. Deletion of PEX35 leads to a
reduction in peroxisome number, and overexpression of PEX35 to
an increase in hyper-fissioned aggregated tiny peroxisomes or to an
early block in the proliferation of peroxisomes. These results,
together with the oleate growth phenotypes, classify Pex35 as a
bona fide peroxin.
We found that C-terminally tagged Pex35 localizes in the vicinity
of the Pex11-type of peroxisome proliferators Pex11, Pex25 and
Pex34, and the small GTPase Arf1. All of these proteins are known
to influence peroxisome abundance (Lay et al., 2006; Thoms and
Erdmann, 2005; Tower et al., 2011), so it is attractive to speculate
Fig. 5. Pex35 is found in proximity to peroxisomal membrane proteins as
well as to Arf proteins. (A) A protein complementation assay for Pex35
interactions reveals a physical proximity to the Pex11, Pex25 and Arf1. Query
strains with Pex35 tagged with either the C- or N-terminal fragment of the
DHFR enzyme were mated with collections of strains expressing the other half
of DHFR in the opposing mating type. Interaction between the Pex35 (bait) and
a screened protein (prey) results in complementation of the DHFR enzyme,
which in turn enables growth on the methotrexate medium, as shown for Ant1
and Pex19. (B) Pex35 is in proximity to Pex11, Pex25 and Arf1. Each of the
three indicated Pex35–prey combinations, shown in the center of each image,
display large colonies, in contrast to the neighboring colonies with other
Pex35–prey combinations. (C) Summary of proteins in proximity to Pex35. Fold
increase colony size: the maximum colony size of four combinations of the
DHFR screen (overexpression or native promoter for PEX35 bait, and two
DHFR fragment collections).
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the Pex35 is part of a regulatory unit that controls peroxisome
fission, and therefore numbers, in the cell. The effect on Arf1 was
particularly intriguing, because ARFs have previously been
implicated in peroxisome formation, but their contribution has
been poorly established. The mammalian ARF proteins Arf1 and
Arf6 have been shown to be present on rat liver peroxisomes, and to
bind to peroxisomes in a GTP-specific manner. Interference with
either Arf1 or Arf6 changes peroxisome morphology (Anthonio
et al., 2009; Lay et al., 2005; Passreiter et al., 1998). In yeast, the
ARF proteins Arf1 and Arf3 are required for peroxisome fission
albeit in opposing manners (Anthonio et al., 2009; Lay et al., 2005).
Additional support of the involvement of ARFs in peroxisome
function comes from the finding that the expression of a dominant-
negative Arf1 mutant, Arf1Q71L, blocks protein transport from the
ER to the peroxisome in plant cells (McCartney et al., 2005).
However, whether ARFs are actively recruited to peroxisomes, how
ARFs affect peroxisomes and how this affects general cellular
trafficking fidelity is still a mystery.
Initially, Pex11 was suggested to be the receptor of ARFs and
coatomer on peroxisomes (Passreiter et al., 1998). This notion was
questioned when it was found that mutations that prevent coatomer
binding to Pex11 had no effect on peroxisome function in yeast or
Fig. 6. Pex35 and peroxisomes control Arf1 distribution and function. (A) Arf1 distribution is impaired in pex35 mutants. While Arf1–RFP is localized in
punctate structures (potentially including Golgi and mitochondria) and partially colocalizes to peroxisomes (white arrowheads) in wild-type (WT) strains, deletion
or overexpression (OE) of PEX35 results in re-distribution to other internal membranes and loss of punctate localization. Scale bar: 5 µm. (B) Synthetic effects of
PEX35 and ARF1mutations. Pex3–GFP was used as a marker to quantify the peroxisome abundance in combinations of Δarf1 and WT, Δpex35 or OE-PEX35.
Scale bar: 5 µm. (C) Quantification of peroxisomal content reveals that deletion of ARF1 aggravates the Δpex35 phenotype of reduced peroxisome number.
Notably, Δarf1 deletion compensated for the effect of PEX35 overexpression on peroxisome abundance. Error bars indicate s.e.m., n>197. ***P<0.01 compared
with WT (t-test). (D) Protein secretion analysis of PEX35 and ARF1 mutants. Images (left; the levels of secretion of Kar2 are indicated) and quantification (right)
of a western blot of Kar2 secreted from six colony repeats per strain. Induction of the UPR (by deletion of SPF1) or loss of peroxisomes (by deletion of PEX3), as
well as overexpression of GFP–Pex35 or ARF1 significantly reduced secretion levels. Deletion of PEX35 compensated for the effect of ARF1 overexpression.
Error bars indicate s.d., n=6. *P<0.1 (not significant); ***P<0.01 (t-test). (E) Deletion ofPEX3 affects cellular Arf1–RFP distribution. In Δpex3 cells, Arf1–RFP loses
its localization to defined puncta. Scale bar: 5 µm.
800
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 791-804 doi:10.1242/jcs.187914
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
trypanosomes (Maier et al., 2000). In addition, the COPI inhibitor,
brefeldin A, does not inhibit peroxisome biogenesis (South et al.,
2000; Voorn-Brouwer et al., 2001). However, today there is new
evidence for the involvement of membrane coats in peroxisome
function (David et al., 2013; Dimitrov et al., 2013; Lay et al., 2006)
and it is becoming clear that peroxisome biogenesis may be distinct
from peroxisome maintenance by fission. Moreover, as we saw in
our own work, fluorescence microscopy alone may not be a
sensitive enough readout for such changes, as sub-diffraction
images can give more detailed information that may be easier to
reconcile with genetic data.
In recent years, reports on non-vesicular functions of ARFs are
becoming more common (Jackson and Bouvet, 2014). We found that
either deletion or overexpression of Pex35 drives Arf1 out of its
physiological localization, mirroring the phenotype of an increased
GAP function or a reduced GEF function, because the active GTP-
bound form of Arf1 is recruited to the membrane, whereas the
inactive GDP-bound form is released from themembrane (Donaldson
and Jackson, 2011). Of note, the Arf1-GEF Sec7 was also found in
the proximity of Pex35 in our DFHR screen (Table S4, rank 29),
although the significance of that interaction remains to be established.
While deletion of Pex35 elevates Arf1 protein levels (Fig. S3A), we
do not understand its mechanistic connection with Arf1. It may very
well be that the upregulation of Arf1 is a consequence of reduced
cellular function and cellular compensation mechanisms. In support
of this, the ability of overexpression of Arf1 to reduce leakage of Kar2
is abolished in the absence of Pex35 (Fig. 6D).
Our findings illuminate both the role of Arf1 as a regulator of
peroxisome abundance and its dependency on healthy peroxisome
biogenesis. Pex35 may be the crucial link in these processes: loss of
focal localization of Arf1 in a peroxisome-defective Δpex3 strain may
be due to the loss of peroxisomal recruitment of Arf1 in this strain.
Intriguingly, Pex35 has domains that show homology with three
human proteins (Fig. S4), two of which have membrane-shaping
properties. One region of Pex35 is homologous to human Rtn1, an
ER reticulon, and another with Epn4, an epsin-related protein that
binds the clathrin coat. Both proteins shape membrane curvature,
which is essential for the fission process. In addition, potential
homology was also found to Pxmp4, a human peroxisomal protein.
These areas of homology suggest that Pex35 functions have been
conserved in humans and they are suggestive of possible
mechanism of Pex35 function.
Our work suggests that regulation of peroxisome size and number
is linked tightly with secretory pathway functions. Physiological
secretion is dependent on the presence of peroxisomes. On the
other hand, peroxisome formation itself requires a functional
secretory pathway. In this way, the metabolic status of the cell could
be coupled to secretion and growth in a simple and elegant
mechanism. Such a cross-talk between these two systems could
have dramatic effects on cellular homeostasis and hence would
impact peroxisomes in health and disease.
MATERIALS AND METHODS
Yeast strains
All yeast strains in this study are based on the BY4741/2 laboratory strains
(Brachmann et al., 1998). Strains created in this study are listed in Table S5.All
genetic manipulations were performed using the lithium acetate, polyethylene
glycol (PEG) and single-stranded DNA (ssDNA) method for transforming
yeast strains (Gietz and Woods, 2006) using plasmids previously described
(Janke et al., 2004; Longtine et al., 1998), as listed in Table S6. Primers for
genetic manipulations and their validation were designed using Primers-4-
Yeast (Yofe and Schuldiner, 2014), as listed in Table S7.
A query strain was constructed by introduction of an ER marker, Spf1–
GFP, and a peroxisome marker, Pex3–mCherry (yMS1233). The query
strain was then crossed into the yeast deletion and hypomorphic allele
collections (Breslow et al., 2008; Giaever et al., 2002) by the synthetic
genetic array method (Cohen and Schuldiner, 2011; Tong and Boone,
2006). Representative strains of the resulting screening library were
validated by inspection for the presence of peroxisomal mCherry and ER-
localized GFP expression. This procedure resulted in a collection of haploid
strains used for screening mutants that display peroxisomal abnormalities.
Automated high-throughput fluorescence microscopy
The screening collection, containing a total of 5878 strains, was visualized
in SD medium during mid-logarithmic growth using an automated
microscopy setup as described previously (Breker et al., 2013).
Automated image analysis
After acquisition, images were analyzed using the ScanR analysis software
(Olympus), by which single cells were recognized based on the GFP signal,
and peroxisomes were recognized based on the mCherry signal (Fig. S1).
Measures of cell and peroxisome size, shape and fluorescent signals were
extracted, and outliers were removed. A total of 5036 mutant strains were
successfully analyzed, with a mean of 126±56 (s.e.m.) cells per strain
(minimum of 30) that passed filtering (Table S1). For each mutant strain, the
mean number of peroxisomes recognized by the software per cell was
extracted, as well as the mean area (in pixels) of peroxisomes. Note that
these are arbitrary units that may only be used to compare between strains, as
resulting values are dependent on the parameters of image analysis and of
the fluorescent markers used.
Microscopy
For follow up microscopy analysis, yeast growth conditions were as
described above for the high-content screening. Imaging was performed
using the VisiScope Confocal Cell Explorer system, composed of a Zeiss
Yokogawa spinning disk scanning unit (CSU-W1) coupled with an inverted
Olympus microscope (IX83; ×60 oil objective; excitation wavelength of
488 nm for GFP, and 561 nm for mCherry). Images were taken by a
connected PCO-Edge sCMOS camera, controlled by VisView software. In
the case of galactose induction of GALp-GFP-PEX35 (Fig. 3F), yeast were
transferred to the microscopy plate, and after adhering to the glass bottom,
medium containing 2% galactose was used to wash the cells and during the
time-lapse imaging.
STED microscopy
Strains were transformed with EYFP–SKL (plasmid PST1219) and
analyzed as described previously (Kaplan and Ewers, 2015) using GFP
nanobodies coupled to Atto647N (gba647n-100, Chromotek, Planegg-
Martinsried). Slides were analyzed on a custom-made STED setup
described previously (Göttfert et al., 2013). Images show unprocessed
raw data. STED images shown in Fig. 3 were rescaled by a factor of two
using bicubic interpolation (Adobe Photoshop). The size of yeast
peroxisomes was calculated as follows. Random peroxisomes were
marked by manually drawing a ROI and the center of masses was
determined. Peroxisome diameter was measured after drawing a line scan
through the minor axis of the peroxisome. The full-width at half-maximum
(FWHM) of the Gaussian fits for each peroxisomal structurewas determined
using an ImageJ macro by John Lim. Average size was quantified for more
than 50 peroxisomes and statistical significance was calculated using a two-
sample t-test (two-tailed, unequal variance).
Oleic acid growth experiments
Growth on oleate, oleate consumption and halo formation was analyzed as
described previously (Nötzel et al., 2016; Rucktäschel et al., 2009; Thoms
et al., 2008).
Isolation of peroxisomes and mitochondria
Preparation of peroxisomes and mitochondria followed published protocols
(Flis et al., 2015; Thoms et al., 2011b). Briefly, yeast cells were grown in
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YPD (1% yeast extract, 2% peptone, 2% glucose) to late exponential phase,
transferred to YPO medium and grown for 48 h. Cells were harvested by
centrifugation (3000 g for 5 min), washed with water and resuspended in
buffer containing 0.1 M Tris-HCl, pH 9.4 and 1.5 mg/ml dithiothreitol
(DTT). Spheroblasts were prepared by using 2 mg Zymolyase 20 T per 1 g
wet weight. Spheroblasts were recovered by centrifugation (3000 g for 10
min), washed twice with 1.2 M sorbitol, homogenized and lysed on ice
using a Dounce homogenizer in breaking buffer [5 mM 2-(N-morpholino)
ethanesulfonic acid (MES), 1 mM potassium chloride, 0.6 M sorbitol,
0.5 mM EDTA, 1 mM phenylmethanesulfonylfluoride (PMSF), pH 6.0
(with KOH)]. Cell debris and nuclei were removed by centrifugation at
3000 g for 5 min. The resulting pellet was collected and subjected to two
further rounds of resuspension in breaking buffer, homogenizing and
centrifugation. The combined (post nuclear) supernatants (PNS) were
centrifuged at 20,000 g in an SS34 rotor (Sorvall) for 30 min. The organelle
pellets containing peroxisomes and mitochondria were collected and gently
resuspended in a small Dounce homogenizer in breaking buffer plus 1 mM
PMSF and centrifuged at low speed (3000 g) for 5 min to remove residual
cellular debris. The supernatant containing the microsomal fraction was
centrifuged at 27,000 g for 10 min. The pellet was resuspended in breaking
buffer and loaded onto a Nycodenz step gradient [steps of 17%, 24%, 35%
(w/v) in 5 mMMES, 1 mM potassium chloride, and 0.24 M sucrose, pH 6.0
(with KOH)]. Centrifugationwas carried out in a swing out rotor (Sorvall AH-
629) at 26,000 rpm for 90 min. Using a syringe, the mitochondrial and the
peroxisomal fraction were collected from the top of the 17% and the 24%–
35% interface, respectively. Purified organelles were diluted in four volumes
of breaking buffer and centrifuged for 15 min at 27,000 g in an SS34 rotor.
Pellets were stored at −20°C before determination of protein concentration
and western blot analysis. Anti-Por1 rabbit antiserum (courtesy of Günther
Daum, Institut für Biochemie, Technische Universität Graz, Austria) was used
at a dilution of 1:2000 to detect mitochondria.
Arf1 protein quantification
Yeast strains used for protein extraction (BY4741 as wild-type, GPD1prom-
PEX35::natNT2 and Δpex35::natNT2) were grown in YPD (with clonat for
Pex35 strains) to the stationary phase and the diluted in YPD to an optical
density at 600 nm (OD600) of 0.2 and further grown until they reached an
OD600 of 0.6–0.8. 2.5 OD600 units of yeast cells were harvested by
centrifugation (3000 g for 3 min). Cells were resuspended in 100 µl distilled
water, 100 µl 0.2 M NaOH was added, and cells were incubated for 5 min at
room temperature, pelleted (3000 g for 3 min), resuspended in 75 µl SDS
sample buffer (0.06 M Tris-HCl pH 6.8, 10% glycerol, 2% SDS, 50 mM
DTT, 2 mM PMSF and 0.0025% Bromophenol Blue), boiled for 5 min at
95°C and pelleted again (20,000 g for 2 min). 25 µl supernatant was loaded
per lane for SDS-PAGE (12% acrylamide) and then transferred to a
nitrocellulose membrane for western blotting. Primary antibody was rabbit
anti-Arf1 (1:2000 dilution, a gift from Chris Fromme, TheWeill Institute for
Cell and Molecular Biology, Cornell University, Ithaca, USA) and
secondary antibody was horseradish peroxidase (HRP)-conjugated anti-
rabbit-IgG. Membranes were exposed in LAS4000 machine using
chemiluminescence reagents. Quantification was performed by ImageJ
relative to a histone H3 loading control.
Protein secretion assay
We analyzed protein secretion as previously described (Copic et al., 2009).
Specifically, yeast strains grown in a 96-colony array format were pinned by
the RoToR colony arrayer onto YEPD agar plates, and a nitrocellulose
membrane was applied onto the plate immediately thereafter. Overnight
incubation at 30°C allowed cell growth and ensured that secreted proteins
were transferred to the nitrocellulose membrane. The membrane was
removed from the plate and then washed (10 mM Tris-HCl, 0.5 M NaCl,
pH 7.5) to release remaining cells. Secreted Kar2 was used as a reporter for
secretion level, and was probed with a primary rabbit antibody (rabbit
polyclonal antiserum, 1:5000 dilution, kindly shared by Peter Walter,
Department of Biochemistry and Biophysics, UCSF, San Francisco, USA).
Next, we used secondary goat anti-rabbit-IgG conjugated to IRDye800
(926-32211, LI-COR Biosciences) and scanned the membrane for infrared
signal using the Odyssey Imaging System (LI-COR Biosciences).
Lipidomics
Quantitative lipid analysis was performed using a Triversa NanoMate ion
source (Advion Biosciences, Inc.) coupled to a LTQ Orbitrap XL mass
spectrometer (Thermo Fisher Scientific), as previously described (Ejsing
et al., 2009).
Glutathione measurements
The thiol–disulfide pair of roGFP2 equilibrates with the glutathione redox
couple. roGFP2 exhibits two fluorescence excitation maxima at ∼400 nm
and ∼480 nm for fluorescence emission is followed at 510 nm. The relative
intensity of fluorescence emission at each excitation maxima changes in the
opposing direction dependent upon whether the roGFP2 thiols are reduced
or forming a disulfide bond, thereby allowing ratiometric fluorescence
imaging of the roGFP2 redox state. Dynamic EGSH measurements were
conducted as previously described in detail (Morgan et al., 2011).
Amino acid analysis
Amino acid analysis was conducted as described previously (Nötzel et al.,
2016).
Protein complementation assay screening
The protein–protein interaction screen was performed using the yeast DHFR
PCA library as previously described (Tarassov et al., 2008). In brief,
strains with Pex35 tagged at its C-terminus with DHFR[1,2] (in MATa), or
DHFR[3] (in MATalpha), and regulated by either the natural PEX35 promoter
(yMS2585/6) or the strong TEF promoter (yMS2589/90), weremated with the
complementary DHFR libraries in 1536 colony array agar plates. The resulting
diploids were subsequently selected for growth in the presence ofmethotrexate
for positive DHFR PCA reconstitution for 5 days at 30°C. The colony array
plates were scanned in two repeats and colony sizes were measured using the
freely available Balony software (Young andLoewen, 2013), with each colony
size normalized by row and column means (Table S4).
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Yofe, I., Soliman, K., Gärtner, J., Thoms, S. et al. (2014). Peroxisomes are
juxtaposed to strategic sites on mitochondria. Mol. Biosyst. 10, 1742-1748.
Colasante, C., Chen, J., Ahlemeyer, B. and Baumgart-Vogt, E. (2015).
Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-
activated receptor-loop. Thromb. Haemost. 113, 452-463.
Copic, A., Dorrington, M., Pagant, S., Barry, J., Lee, M. C. S., Singh, I., Hartman,
J. L. and Miller, E. A. (2009). Genomewide analysis reveals novel pathways
affecting endoplasmic reticulum homeostasis, protein modification and quality
control. Genetics 182, 757-769.
David, C., Koch, J., Oeljeklaus, S., Laernsack, A., Melchior, S., Wiese, S.,
Schummer, A., Erdmann, R., Warscheid, B. and Brocard, C. (2013). A
combined approach of quantitative interaction proteomics and live-cell imaging
reveals a regulatory role for endoplasmic reticulum (ER) reticulon homology
proteins in peroxisome biogenesis. Mol. Cell Proteomics 12, 2408-2425.
Dimitrov, L., Lam, S. K. and Schekman, R. (2013). The role of the endoplasmic
reticulum in peroxisome biogenesis. Cold Spring Harb. Perspect. Biol. 5,
a013243-a013243.
Dixit, E., Boulant, S., Zhang, Y., Lee, A. S. Y., Odendall, C., Shum, B., Hacohen,
N., Chen, Z. J., Whelan, S. P., Fransen, M. et al. (2010). Peroxisomes are
signaling platforms for antiviral innate immunity. Cell 141, 668-681.
Donaldson, J. G. and Jackson, C. L. (2011). ARF family G proteins and their
regulators: roles in membrane transport, development and disease.Nat. Rev. Mol.
Cell Biol. 12, 362-375.
Eden, E., Navon, R., Steinfeld, I., Lipson, D. and Yakhini, Z. (2009). GOrilla: a tool
for discovery and visualization of enriched GO terms in ranked gene lists. BMC
Bioinformatics 10, 48.
Effelsberg, D., Cruz-Zaragoza, L. D., Schliebs, W. and Erdmann, R. (2016).
Pex9p is a novel yeast peroxisomal import receptor for PTS1-proteins. J. Cell. Sci
129, 4057-4066.
Eisenberg-Bord, M. and Schuldiner, M. (2016). Ground control to major TOM:
mitochondria-nucleus communication. FEBS J., doi:10.1111/febs.13778 [Epub].
Ejsing, C. S., Sampaio, J. L., Surendranath, V., Duchoslav, E., Ekroos, K.,
Klemm, R. W., Simons, K. and Shevchenko, A. (2009). Global analysis of the
yeast lipidome by quantitative shotgun mass spectrometry. Proc. Natl. Acad. Sci.
USA 106, 2136-2141.
Elbaz-Alon, Y., Morgan, B., Clancy, A., Amoako, T. N. E., Zalckvar, E., Dick,
T. P., Schwappach, B. and Schuldiner, M. (2014). The yeast oligopeptide
transporter Opt2 is localized to peroxisomes and affects glutathione redox
homeostasis. FEMS Yeast Res. 14, 1055-1067.
Emanuelsson, O., Brunak, S., von Heijne, G. and Nielsen, H. (2007). Locating
proteins in the cell using TargetP, SignalP and related tools. Nat. Protoc. 2,
953-971.
Eubel, H., Meyer, E. H., Taylor, N. L., Bussell, J. D., O’Toole, N., Heazlewood,
J. L., Castleden, I., Small, I. D., Smith, S. M. and Millar, A. H. (2008). Novel
proteins, putative membrane transporters, and an integrated metabolic network
are revealed by quantitative proteomic analysis of Arabidopsis cell culture
peroxisomes. Plant Physiol. 148, 1809-1829.
Flis, V. V., Fankl, A., Ramprecht, C., Zellnig, G., Leitner, E., Hermetter, A. and
Daum, G. (2015). Phosphatidylcholine Supply to Peroxisomes of the Yeast
Saccharomyces cerevisiae. PLoS One 10, e0135084.
Fransen, M., Nordgren, M., Wang, B., Apanasets, O. and Van Veldhoven, P. P.
(2013). Aging, age-related diseases and peroxisomes. Subcell. Biochem. 69,
45-65.
Fukao, Y., Hayashi, M. and Nishimura, M. (2002). Proteomic analysis of leaf
peroxisomal proteins in greening cotyledons of Arabidopsis thaliana. Plant Cell
Physiol. 43, 689-696.
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Véronneau, S., Dow, S.,
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Magalhaẽs, A. C., Ferreira, A. R., Gomes, S., Vieira, M., Gouveia, A., Valença, I.,
Islinger, M., Nascimento, R., Schrader, M., Kagan, J. C. et al. (2016).
Peroxisomes are platforms for cytomegalovirus’ evasion from the cellular immune
response. Sci. Rep. 6, 26028.
Maier, A. G., Schulreich, S., Bremser, M. and Clayton, C. (2000). Binding of
coatomer by the PEX11 C-terminus is not required for function. FEBS Lett. 484,
82-86.
Marelli, M., Smith, J. J., Jung, S., Yi, E., Nesvizhskii, A. I., Christmas, R. H.,
Saleem, R. A., Tam, Y. Y. C., Fagarasanu, A., Goodlett, D. R. et al. (2004).
Quantitative mass spectrometry reveals a role for the GTPase Rho1p in actin
organization on the peroxisome membrane. J. Cell Biol. 167, 1099-1112.
McCartney, A.W., Greenwood, J. S., Fabian,M. R.,White, K. A. andMullen, R. T.
(2005). Localization of the tomato bushy stunt virus replication protein p33 reveals
803
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 791-804 doi:10.1242/jcs.187914
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
a peroxisome-to-endoplasmic reticulum sorting pathway. Plant Cell 17,
3513-3531.
Mi, J., Kirchner, E. and Cristobal, S. (2007). Quantitative proteomic comparison of
mouse peroxisomes from liver and kidney. Proteomics 7, 1916-1928.
Mohanty, A. and McBride, H. M. (2013). Emerging roles of mitochondria in the
evolution, biogenesis, and function of peroxisomes. Front. Physiol. 4, 268.
Morgan, B., Sobotta, M. C. and Dick, T. P. (2011). Measuring E(GSH) and H2O2
with roGFP2-based redox probes. Free Radic. Biol. Med. 51, 1943-1951.
Natarajan, K., Meyer, M. R., Jackson, B. M., Slade, D., Roberts, C., Hinnebusch,
A. G. and Marton, M. J. (2001). Transcriptional profiling shows that Gcn4p is a
master regulator of gene expression during amino acid starvation in yeast. Mol.
Cell. Biol. 21, 4347-4368.
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